This is our hint to a deal. Just realized after t
Post# of 148187
(Total Views: 518)
Posted On: 10/16/2024 2:23:45 AM
This is our hint to a deal.
Just realized after this part :
*announced our selection of Syneos Health to serve as our clinical research organization (“CRO”) and implement our FDA-approved protocol to evaluate leronlimab in the treatment of patients with HIV and chronic inflammation
*and expect to start screening patients in December 2024.
Pay the sites. Training doctors & staff. Etc, etc..
But based on the # of patients, you also need to have that per patient cost banked away.
Repeat for early 2025 start of screening.
With these very near costs & maintaining a % of your cash, for on hand threshold levels, it all looks to me we are indeed very close to some great developments occurring.
Just realized after this part :
*announced our selection of Syneos Health to serve as our clinical research organization (“CRO”) and implement our FDA-approved protocol to evaluate leronlimab in the treatment of patients with HIV and chronic inflammation
*and expect to start screening patients in December 2024.
Pay the sites. Training doctors & staff. Etc, etc..
But based on the # of patients, you also need to have that per patient cost banked away.
Repeat for early 2025 start of screening.
With these very near costs & maintaining a % of your cash, for on hand threshold levels, it all looks to me we are indeed very close to some great developments occurring.
(5)
(1)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼